- Home
- NVRI vs PSNL Comparison
NVRI vs PSNL Comparison
Compare NVRI & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- PSNL
- Stock Information
- Founded
- NVRI 1853
- PSNL 2011
- Country
- NVRI United States
- PSNL United States
- Employees
- NVRI N/A
- PSNL N/A
- Industry
- NVRI Diversified Commercial Services
- PSNL Medical Specialities
- Sector
- NVRI Miscellaneous
- PSNL Health Care
- Exchange
- NVRI Nasdaq
- PSNL Nasdaq
- Market Cap
- NVRI 996.0M
- PSNL 854.8M
- IPO Year
- NVRI N/A
- PSNL 2019
- Fundamental
- Price
- NVRI $18.17
- PSNL $10.02
- Analyst Decision
- NVRI
- PSNL Strong Buy
- Analyst Count
- NVRI 0
- PSNL 7
- Target Price
- NVRI N/A
- PSNL $10.43
- AVG Volume (30 Days)
- NVRI 2.0M
- PSNL 1.6M
- Earning Date
- NVRI 11-10-2025
- PSNL 11-04-2025
- Dividend Yield
- NVRI N/A
- PSNL N/A
- EPS Growth
- NVRI N/A
- PSNL N/A
- EPS
- NVRI N/A
- PSNL N/A
- Revenue
- NVRI $2,244,061,000.00
- PSNL $69,103,000.00
- Revenue This Year
- NVRI N/A
- PSNL N/A
- Revenue Next Year
- NVRI $3.72
- PSNL $29.83
- P/E Ratio
- NVRI N/A
- PSNL N/A
- Revenue Growth
- NVRI N/A
- PSNL N/A
- 52 Week Low
- NVRI $4.72
- PSNL $2.83
- 52 Week High
- NVRI $18.59
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- NVRI 85.04
- PSNL 63.58
- Support Level
- NVRI $12.87
- PSNL $7.11
- Resistance Level
- NVRI $18.59
- PSNL $9.89
- Average True Range (ATR)
- NVRI 0.76
- PSNL 0.89
- MACD
- NVRI 0.47
- PSNL 0.13
- Stochastic Oscillator
- NVRI 93.55
- PSNL 94.47
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.